Q32 Bio Inc.
General ticker "QTTB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $36.7M (TTM average)
Q32 Bio Inc. follows the US Stock Market performance with the rate: 29.2%.
Estimated limits based on current volatility of 6.3%: low 5.59$, high 6.34$
Factors to consider:
- Total employees count: 124 as of 2018
- Current price 30.0% above estimated high
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.13$, 4.54$]
- 2026-12-31 to 2027-12-31 estimated range: [2.14$, 4.50$]
Short-term QTTB quotes
Long-term QTTB plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $53.74MM |
| Operating Expenses | $36.84MM |
| Operating Income | $16.90MM |
| Non-Operating Income | $12.92MM |
| Interest Expense | $1.10MM |
| R&D Expense | $19.16MM |
| Income(Loss) | $29.82MM |
| Profit(Loss)* | $77.00MM |
| Stockholders Equity | $42.01MM |
| Assets | $61.78MM |
| Operating Cash Flow | $-33.54MM |
| Capital expenditure | $0.00MM |
| Investing Cash Flow | $7.00MM |
| Financing Cash Flow | $-3.12MM |
| Earnings Per Share** | $6.26 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.